Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$22.82 -0.19 (-0.83%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2014 - 2016)

Updated

Viridian Therapeutics, Inc.\DE's Current Leases came in at $4,000 for Q4 2016, down 95.5% from $88,000 a year earlier.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2014 - 2016) Analysis & Trends

  • Going back by year, Current Leases was $88,000 in FY2015 (+10.0%) and $80,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Viridian Therapeutics, Inc.\DE 2.58 Bn -525.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 4,000.00
Dec 31, 2015 88,000.00
Dec 31, 2014 80,000.00
API Access

Viridian Therapeutics, Inc.\DE Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=VRDN&period=max&api_key=YOUR_API_KEY